National Health Investors (NYSE:NHI) Share Price Crosses Above 200-Day Moving Average – Should You Sell?
by Renee Jackson · The Cerbat GemNational Health Investors, Inc. (NYSE:NHI – Get Free Report)’s stock price passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $80.40 and traded as high as $86.23. National Health Investors shares last traded at $84.8760, with a volume of 301,761 shares trading hands.
More National Health Investors News
Here are the key news stories impacting National Health Investors this week:
- Positive Sentiment: Announced sale of a 35‑property portfolio (32 skilled nursing + 3 independent living) to National HealthCare Corporation for $560.0M; company says the deal strengthens the balance sheet and accelerates capital recycling into private‑pay senior housing (expected close July 1, 2026; $6–8M of transaction costs). This is a material portfolio disposition that should increase liquidity and free up capital for higher‑growth / higher‑margin investments. NHI Announces Sale of NHC Portfolio for $560 Million
- Positive Sentiment: Cantor Fitzgerald reaffirmed its “overweight” rating and kept a $94 price target, implying meaningful upside from current levels — a vote of confidence from a sell‑side firm that may support the stock once the market digests the transaction. Cantor Fitzgerald Reaffirmation
- Neutral Sentiment: Blueprint Healthcare Real Estate Advisors is advising NHI on the transaction — a standard advisory engagement that signals the company is using specialized advisors for execution but does not change the deal economics itself. Blueprint Advisor Announcement
- Neutral Sentiment: Truist trimmed its price target from $92 to $89 but maintained a “buy” rating — modestly lower upside expectations but still constructive on the name. Truist Price Target Change
- Negative Sentiment: Wells Fargo cut its price target to $84 and moved to “equal weight,” reducing near‑term analyst support and likely contributing to selling pressure. The lower rating signals less conviction from at least one institutional investor group. Wells Fargo Price Target Cut
Analyst Upgrades and Downgrades
NHI has been the subject of a number of research reports. National Bank Financial set a $85.00 target price on shares of National Health Investors in a report on Tuesday, January 20th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of National Health Investors in a report on Friday, March 27th. Deutsche Bank Aktiengesellschaft cut shares of National Health Investors from a “buy” rating to a “hold” rating and set a $85.00 target price for the company. in a report on Tuesday, January 20th. Wells Fargo & Company reduced their target price on shares of National Health Investors from $86.00 to $84.00 and set an “equal weight” rating for the company in a report on Wednesday. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $94.00 target price on shares of National Health Investors in a report on Wednesday. One equities research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $87.50.
Get Our Latest Analysis on National Health Investors
National Health Investors Stock Down 8.3%
The stock has a market capitalization of $3.70 billion, a PE ratio of 25.31, a PEG ratio of 4.54 and a beta of 0.63. The firm’s fifty day moving average is $85.29 and its 200-day moving average is $80.41. The company has a quick ratio of 6.90, a current ratio of 6.90 and a debt-to-equity ratio of 0.76.
National Health Investors (NYSE:NHI – Get Free Report) last posted its quarterly earnings results on Thursday, February 26th. The real estate investment trust reported $1.22 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.23 by ($0.01). The firm had revenue of $105.82 million for the quarter, compared to analysts’ expectations of $95.12 million. National Health Investors had a return on equity of 9.56% and a net margin of 37.81%.The company’s revenue for the quarter was up 6.8% on a year-over-year basis. During the same period in the prior year, the company earned $1.24 earnings per share. National Health Investors has set its FY 2026 guidance at 4.940-4.990 EPS. On average, equities research analysts predict that National Health Investors, Inc. will post 5.02 earnings per share for the current year.
National Health Investors Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, May 1st. Investors of record on Tuesday, March 31st will be issued a dividend of $0.92 per share. This represents a $3.68 annualized dividend and a yield of 4.8%. The ex-dividend date of this dividend is Tuesday, March 31st. National Health Investors’s dividend payout ratio is currently 121.85%.
Institutional Inflows and Outflows
Large investors have recently added to or reduced their stakes in the company. International Assets Investment Management LLC purchased a new position in National Health Investors during the fourth quarter worth about $27,000. EverSource Wealth Advisors LLC grew its position in National Health Investors by 244.1% during the second quarter. EverSource Wealth Advisors LLC now owns 406 shares of the real estate investment trust’s stock worth $28,000 after buying an additional 288 shares during the period. Garton & Associates Financial Advisors LLC acquired a new position in National Health Investors during the fourth quarter worth about $33,000. GAMMA Investing LLC grew its position in National Health Investors by 41.8% during the fourth quarter. GAMMA Investing LLC now owns 461 shares of the real estate investment trust’s stock worth $35,000 after buying an additional 136 shares during the period. Finally, Key Capital Management INC acquired a new position in National Health Investors during the fourth quarter worth about $47,000. 62.51% of the stock is owned by hedge funds and other institutional investors.
National Health Investors Company Profile
National Health Investors, Inc (NYSE: NHI) is a specialized real estate investment trust (REIT) focused on owning and financing high-quality healthcare and senior housing facilities in the United States. The company’s portfolio encompasses a diverse range of properties, including skilled nursing centers, assisted living and memory care communities, behavioral health facilities, dialysis clinics, and medical office buildings. NHI typically enters into long-term net-lease agreements with experienced healthcare operators, providing stable and predictable rental income streams while enabling its tenants to concentrate on delivering quality care.
Since its founding in 1991 and initial public offering later that year, National Health Investors has pursued a disciplined growth strategy centered on strategic acquisitions, joint ventures, and selective development.